Krishna Institute of Medical Sciences Limited (KIMS.BO)
- Previous Close
669.60 - Open
660.05 - Bid 673.25 x --
- Ask 674.05 x --
- Day's Range
660.05 - 685.00 - 52 Week Range
350.02 - 707.50 - Volume
30,906 - Avg. Volume
25,052 - Market Cap (intraday)
275.555B - Beta (5Y Monthly) -0.10
- PE Ratio (TTM)
69.93 - EPS (TTM)
9.64 - Earnings Date Aug 5, 2025 - Aug 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
708.31
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, Alzheimer's, bone, joint center specialties, and others. In addition, the company provides medical procedures for aneurysm, ankle arthritis and total ankle replacement, anterior cervical discectomy and fusion surgery, anterior resection, aortic aneurysm, aortic stent graft, aortic valve replacement, arthroscopy, atrial septal defect, bariatric surgery, and others. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.
www.kimshospitals.comRecent News: KIMS.BO
View MorePerformance Overview: KIMS.BO
Trailing total returns as of 6/3/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KIMS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KIMS.BO
View MoreValuation Measures
Market Cap
267.93B
Enterprise Value
291.98B
Trailing P/E
69.68
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.83
Price/Book (mrq)
12.53
Enterprise Value/Revenue
9.62
Enterprise Value/EBITDA
35.37
Financial Highlights
Profitability and Income Statement
Profit Margin
12.67%
Return on Assets (ttm)
7.90%
Return on Equity (ttm)
18.39%
Revenue (ttm)
30.35B
Net Income Avi to Common (ttm)
3.84B
Diluted EPS (ttm)
9.64
Balance Sheet and Cash Flow
Total Cash (mrq)
1.02B
Total Debt/Equity (mrq)
105.70%
Levered Free Cash Flow (ttm)
-4.46B